/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

K

Kathy Nicholls

The Royal Melbourne Hospital(AU)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

262

Papers

8.1K

Citations

47

h-index

123

i10-index

Kathy Nicholls is an academic researcher from The Royal Melbourne Hospital. The author has contributed to research in topics: Lysosomal Storage Disorders Research & Carbohydrate Chemistry and Synthesis & Renal Diseases and Glomerulopathies. The author has an h-index of 47, co-authored 223 publications.

ORCID: 0000-0002-1297-8722

Research Topics

Lysosomal Storage Disorders Research Carbohydrate Chemistry and Synthesis Renal Diseases and Glomerulopathies Trypanosoma species research and implications Glycogen Storage Diseases and Myoclonus

Papers by this author

works

Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

2022 · Kidney International · 169 citations

https://doi.org/10.1016/j.kint.2022.03.019

Anna Köttgen Émilie Cornec-Le Gall Jan Halbritter Krzysztof Kiryluk

HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome

2014 · Journal of the American Society of Nephrology · 145 citations

https://doi.org/10.1681/asn.2014030247

Rasheed Gbadegesin Adebowale Adeyemo Nicholas J.A. Webb Larry A. Greenbaum

Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study

2019 · Genetics in Medicine · 94 citations

https://doi.org/10.1038/s41436-019-0451-z

Dominique P. Germain Kathy Nicholls Roberto Giugliani Daniel G. Bichet

Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study

2020 · Molecular Genetics and Metabolism · 74 citations

https://doi.org/10.1016/j.ymgme.2020.07.007

Ulla Feldt‐Rasmussen Derralynn Hughes Gere Sunder‐Plassmann Suma P. Shankar

Long-term follow-up of renal function in patients treated with migalastat for Fabry disease

2021 · Molecular Genetics and Metabolism Reports · 36 citations

https://doi.org/10.1016/j.ymgmr.2021.100786

Daniel G. Bichet Roser Torrá Eric Wallace Derralynn Hughes

Fabry in the older patient: Clinical consequences and possibilities for treatment

2016 · Molecular Genetics and Metabolism · 17 citations

https://doi.org/10.1016/j.ymgme.2016.05.009

Olivier Lidove Frédéric Barbey Dau‐Ming Niu Eva Brand

Research topics

topics

Lysosomal Storage Disorders Research

Carbohydrate Chemistry and Synthesis

Renal Diseases and Glomerulopathies

Trypanosoma species research and implications

Glycogen Storage Diseases and Myoclonus

Chat about Author

Papers

Chat

Click to start Chat